When was Benchling founded?

Benchling was founded in 2012 and became a unicorn in 2021, reaching the milestone in 9 years. It raised its 1st funding round 2 years after its incorporation.

Where is Benchling located?

Benchling is headquartered in San Francisco, United States. It is registered at San Francisco, California.

Who is the current CEO of Benchling?

Sajith Wickramasekara of Benchling. They are also an angel investors in 1 startup.

Which legal entities is Benchling associated with?

Benchling is associated with BENCHLING, INC..

How many employees does Benchling have?

As of Mar 31, 2026, the latest employee count at Benchling is 796.

Is Benchling a funded company?

Benchling is a funded company, having raised a total of $412M across 9 funding rounds to date. The company's 1st funding round was a $900K Seed round, raised on Feb 20, 2014.

How much is Benchling worth?

The latest valuation of Benchling is $6.1B as of Nov 18, 2021.

When was the latest funding round of Benchling?

Benchling's latest funding was a $100M Series F round on Nov 18, 2021, with participation from 4 investors.

Is Benchling a Genomics company?

The primary sectors of Benchling are Genomics and Life Sciences Tech.

Where does Benchling rank among its competitors?

Benchling ranks 1st amongst 427 active competitors, of which 79 are funded. It stands 2nd in terms of total funding among its competitors. The most recent competitor to raise funding was NTxBio, which secured $10.4M in Nov, 2025.

Who are the top competitors of Benchling?

Benchling's top competitors include Helix, Recludix Pharma and Immuneering Corporation. Among them, NTxBio secured the most recent funding round in November, 2025.

Benchling - 2026 Company Profile, Team, Funding & Competitors

Sectors and market segments that Benchling operate in

Benchling serves in the Life Sciences, HealthTech market segments.The primary business model of Benchling are:

Company Details

Provider of a cloud-based bioinformatics platform for biotech research It includes the premier suite for molecular biology research: CRISPR guide design, automated Gibson and Golden Gate cloning, primer design, multiple sequence alignment, and more. Other apps include image analysis like gel annotation and colony counting and protocol design with spreadsheet functionality. The company's tools are cloud-based and so can be shared with people instantly.

Website: www.benchling.com
Social
Registered Address: San Francisco, California

Key Metrics

Founded Year

2012

Location

San Francisco, United States

Stage

Series F

Total Funding

$412M in 9 rounds

Latest Funding Round

Series F, Nov 18, 2021, $100M

Post Money Valuation

$6.1B as on Nov 18, 2021

Investors

Altimeter Capital & 29 more

Ranked

1^st among 427 active competitors

Employee Count

796 as on Mar 31, 2026

Investment & Acquisitions

Overwatch Research & 1 more

Similar Companies

Helix & 598 more

View Benchling's full profile

Benchling is associated with 1 legal entity given below:

Legal Entity Name	Date of Incorporation	Revenue	Latest Employee Count	Documents
BENCHLING, INC. CIN: 455365648 , United States, Active	Dec 31, 2011	-	600 (As on Dec 31, 2024)	-

Benchling has raised a total funding of $412M over 9 rounds. Its first funding round was on Feb 20, 2014. Its latest funding round was a Series F round on Nov 18, 2021 for $100M. 4 investors participated in its latest round. Benchling has 29 institutional investors and 1 angel investor.

Here is the list of recent funding rounds of Benchling:

Filter this list

Date of Funding	Funding Amount	Round Name	Post-Money Valuation	Revenue Multiple	Lead Investors	Other Investors
Nov 18, 2021	$100M	Series F	$6.1B	-	Altimeter Capital, Franklin Templeton Investments	Tiger Global Management, Lone Pine Capital
Apr 14, 2021	$200M	Series E	$4B	-	Altimeter Capital, Elad Gil, Sequoia Capital	Thrive Capital, Menlo Ventures, Alkeon Capital Management, Lux Capital, Spark Capital, Iconiq Capital, Benchmark, Lead Edge Capital, Byers Capital
May 29, 2020	$50M	Series D	-	-	Alkeon Capital Management	Lux Capital, Thrive Capital, Menlo Ventures, Benchmark Email, Spark Capital, ICONIQ Growth

Access funding benchmarks and valuations. Sign up today!

View details of Benchling's funding rounds and investors

The founders of Benchling are Ashu Singhal and Sajith Wickramasekara.

Here are the details of Benchling's key team members:

Ashu Singhal: Co-Founder & President of Benchling. They are also an angel investor in 1 startup.
Contact Info: 1 email address
Sajith Wickramasekara: Co-Founder & CEO of Benchling. They are also an angel investor in 1 startup.
Contact Info: 1 email address

View details of Benchling's Founder profiles and Board Members

Benchling's employee count trend

Benchling has 796 employees as of Mar 26. Here is Benchling's employee count trend over the years:

Uncover Benchling's growth story! Sign up today!

Access Tracxn on any website

Our Google Chrome extension lets you view company details while browsing their websites

Install Tracxn Extension

Top competitors of Benchling include Helix, Recludix Pharma and Immuneering Corporation. Here is the list of Top 10 competitors of Benchling, ranked by Tracxn score:

Rank	Company Details	Short Description	Total Funding	Investors	Tracxn Score
1st	Benchling 2012, San Francisco (United States), Series F	Provider of a cloud-based bioinformatics platform for biotech research	$412M	Benchmark, Lone Pine Capital & 28 others	73/100
2nd	Helix 2015, San Francisco (United States), Series E	Provider of a genomic database for clinical research	$435M	Warburg Pincus, DFJ Growth & 12 others	71/100
3rd	Recludix Pharma 2020, San Diego (United States), Series A	Provider of the online platform for drug discovery and development	$60M	Access Industries, New Enterprise Associates ... & 1 others	60/100
4th	Immuneering Corporation 2019, Cambridge (United States), Public	Provider of an AI-enabled bioinformatics platform for clinical solutions	$79M	T. Rowe Price, Citadel & 4 others	60/100
5th	NTxBio 2016, Santa Fe (United States), Series B	Provider of bio informatics platform to develops biologics and therapeutics	$85.1M	RA Capital Management, Anzu Partners & 5 others	60/100
6th	Genoox 2012, Tel Aviv (Israel), Acquired	Cloud-based platform for storing and managing genomic data	$20M	Glilot Capital Partners, Inimiti & 9 others	58/100
7th	Latch 2021, San Francisco (United States), Series A	Provider of a web-based platform for genomic bioinformatics	$33M	Lux Capital, Coatue & 7 others	58/100
8th	Genedata 1997, Basel (Switzerland), Acquired	Software solutions for drug discovery, industrial biotechnology, and life science research	-	Novartis Venture Fund, Alta Partners & 1 others	58/100
9th	Inpharmatica 1998, London (United Kingdom), Acquired	Developer of predictive informatics based platform for drug discovery	$75M	Vertex Ventures, Advent Life Sciences & 6 others	58/100
10th	BostonGene 2015, Waltham (United States), Series B	Developer of cloud-based information and analytics platform to treat cancer	$200M	NEC, Japan Industrial Partners & 1 others	57/100